Mesoblast (MEOBF) Net Equity Issued and Repurchased (2014 - 2023)

Mesoblast has disclosed Net Equity Issued and Repurchased across 8 years of filings, most recently posting $43.6 million for Q2 2023.

• In Q2 2023, Net Equity Issued and Repurchased changed N/A year-over-year to $43.6 million; the TTM figure through Jun 2023 stood at $43.6 million (up 20746.89% YoY), while the FY2026 annual figure was $2.6 million, down 98.39% from the prior year.
• Net Equity Issued and Repurchased came in at $43.6 million for Q2 2023 at Mesoblast, up from $62000.0 in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $96.0 million in Q1 2021 to a low of $62000.0 in Q4 2021.
• Average Net Equity Issued and Repurchased over 4 years is $25.3 million, with a median of $4.8 million recorded in 2020.
• Year-over-year, Net Equity Issued and Repurchased soared 2620.4% in 2020 and slumped 98.19% in 2021.
• Over 4 years, Net Equity Issued and Repurchased stood at $51.1 million in 2019, then slumped by 97.2% to $1.4 million in 2020, then sank by 95.67% to $62000.0 in 2021, then surged by 70174.19% to $43.6 million in 2023.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $43.6 million in Q2 2023, $62000.0 in Q4 2021, and $147000.0 in Q3 2021.